Wednesday, August 29, 2007

WHAT IS LUNESTA?

LUNESTA (eszopiclone) is a nonbenzodiazepine hypnotic agent that is a pyrrolopyrazine derivative of the cyclopyrrolone class.

Eszopiclone is a white to light-yellow crystalline solid.

LUNESTA tablets contain
  • 1 mg, 2 mg, or 3 mg eszopiclone and
  • the following inactive ingredients:
  • calcium phosphate,
  • colloidal silicon dioxide,
  • croscarmellose sodium,
  • hypromellose,
  • lactose,
  • magnesium stearate,
  • microcrystalline cellulose,
  • polyethylene glycol,
  • titanium dioxide, and
  • triacetin.

In addition, both the 1 mg and 3 mg tablets contain FD&C Blue #2.

The precise mechanism of action of eszopiclone as a hypnotic is unknown, but its effect is believed to result from its interaction with GABA-receptor complexes at binding domains located close to or allosterically coupled to benzodiazepine receptors.

Eszopiclone is a nonbenzodiazepine hypnotic that is a pyrrolopyrazine derivative of the cyclopyrrolone class with a chemical structure unrelated to pyrazolopyrimidines, imidazopyridines, benzodiazepines, barbiturates, or other drugs with known hypnotic properties.

No comments:

Disclaimer:

This publications contains the opinions and ideas of its author(s). It is intended to provide helpful and informative material on the subjects addressed. It is written with the understanding that the author(s) is (are) not engaged in rendering medical, health, or any other kind of professional service(s). The reader should consult his or her medical, health or other competent professional before adopting any of the suggestions. The author(s) specifically disclaim all responsibility for any liability, loss, or risk, personal or otherwise, which is incurred as a consequence, directly or indirectly, of the use and application of any of the contents of this site.